Supplier Type
- contract manufacturer
- Manufacturer
- Trader
- custom synthesis
- Reagent
Supplier Region
- Hyderabad(15)
- Maharashtra(99)
- Ahmedabad(2)
- Kerela(1)
- Gujarat(77)
- Telangana(42)
- Haryana(3)
- Bangalore(2)
- Mumbai(12)
- Uttar Pradesh(5)
- Karnataka(11)
- Rajasthan(3)
- Vadodara(2)
- AndhraPradesh(1)
- New Delhi(14)
- West Bengal(4)
- Punjab(4)
- Madhya Pradesh(7)
- Tamil Nadu(7)
- GOA(1)
- Pune(1)
- Kolkata(1)
- Andhra Pradesh(2)
- Himachal Pradesh(1)
- NaviMumbai(1)
Purity
- USP
- IP/BP/USP
- IP/BP/EP/USP
- IP / BP
- IH
- above 90 %
- 99.55
- 99.50 %
- 99% Min
- 99%
- 98+
- 98%
- 95%
- 90%
- 90 % Above
- 0.98
Package
- 0Std Packing
- 0Metric Ton
- 500mg
- 1kg
- 5kg
- 102510 Kg / 25 Kg
- 25mg
- 50mg
- 100mg
- 250mg
- 25125kg and 1 MT
- 1g
- 5g
- 10g
- 10kg
- 50010500 mg and 1.0 gm
- 1 kg
- 5 kg
- 10 kg
- 1001100mg and 1 g
- 20KG
- 25kg
- 100kg
- 1grms kgs and MT
- 1grms to kgs
- 1grms kgs amd MT
- 1MT
-
Linagliptin Impurity D
666816-91-7
-
Linagliptin iMpurity G
668270-11-9
-
1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-3-methyl-1,7-bis[(4-methyl-2-quinazolinyl)methyl]-
2138392-83-1
-
Linagliptin Impurity F
1673546-62-7
-
Linagliptin Impurity K
1638744-06-5
-
Linagliptin Impurity S
668273-74-3
-
2 - (ChloracetylaMino)acetophenon
6140-11-0
-
1H-Purine-2,6-dione, 8-[(3R)-3-aMino-1-piperidinyl]-7-[(2E)-3-broMo-2-buten-1-yl]-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-
1446263-39-3
-
Linagliptin Impurity C
1791405-13-4
-
Linagliptin Impurity 10
1911621-52-7
Ligliptin impurity U 666816-91-7
100mg and 1 g 50mg 25mg
DOMPERIDONE EP IMPURITY D 1614255-34-3
Telmisartan EP impurity B 1026353-20-7
Dapagliflozin 1,4-Anhydro impurity 1469910-70-0
Valsartan n-Propyl Impurity 952652-79-8
Methocarbamol Dioxolone Impurity 2049-21-0
Valsartan n-Propyl Impurity 952652-79-8